Delfi Diagnostics
Highly Engaged Employees
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1810 Embarcadero Rd Ste 100, Palo Alto, ...Phone Number
(800) 589-2182Website
www.delfidiagnostics.comRevenue
$6.1 MillionIndustry
About Delfi Diagnostics
DELFI Diagnostics specializes in early cancer detection through its innovative Fragmentomics Platform, which utilizes advanced machine learning and next-generation sequencing to analyze cell-free DNA from liquid biopsy samples. Their flagship products include FirstLookLung for both healthcare providers and patients, as well as DELFI-TF for treatment monitoring. The company aims to serve healthcare systems, pharmaceutical partners, and patients by providing scalable and effective cancer screening solutions. With a leadership team comprising experts in genomics, AI, and cancer biology, DELFI is committed to transforming cancer care and improving patient outcomes.Explore more
SIC Code 87,873NAICS Code 54,541Show moreDelfi Diagnostics Org Chart
Compare Similar Companies to Delfi Diagnostics
Compare insights from companies similar to Delfi Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Delfi Diagnostics Tech Stack
A closer look at the technologies used by Delfi Diagnostics
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding Delfi Diagnostics
Sign Up For FreeTo access detailed company insights
DELFI Diagnostics specializes in early cancer detection through its innovative Fragmentomics Platform, which utilizes advanced machine learning and next-generation sequencing to analyze cell-free DNA from liquid biopsy samples. Their flagship products include FirstLookLung for both healthcare providers and patients, as well as DELFI-TF for treatmen... Read More